Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/136778
| Title: | The opportunity cost of funding new medicines: an attempt to measure the invisible | Other Titles: | El coste de oportunidad de financiar nuevos medicamentos: un intento de medir lo invisible | Authors: | Vallejo Torres, Laura Vanness, David J. Paulden, Mike Claxton, Karl |
UNESCO Clasification: | 531207 Sanidad | Keywords: | National Institute Care Excellence Health |
Issue Date: | 2025 | Journal: | Gaceta Sanitaria | URI: | http://hdl.handle.net/10553/136778 | ISSN: | 0213-9111 | DOI: | 10.1016/j.gaceta.2025.102460 | Source: | Gaceta Sanitaria[ISSN 0213-9111],v. 39, (Enero 2025) |
| Appears in Collections: | Comentario |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.